酪氨酸激酶抑制剂时代完全缓解状态下Ph染色体阳性急性淋巴细胞白血病异基因造血干细胞移植预后分析

OBJECTIVE: To study the clinical results and prognostic factors for allo-HSCT of Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia (ALL) in complete remission (CR) in the era of tyrosine kinase inhibitors (TKI). METHODS: We performed a retrospective analysis of the clinical chara...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Zhonghua Xue Ye Xue Za Zhi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Editorial office of Chinese Journal of Hematology 2020
Gaiak:
论著
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449779/
https://ncbi.nlm.nih.gov/pubmed/32810963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.07.006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak